In October, we sat down with leaders from Globus Medical to discuss their surprising entrance into the joint replacement market and robotics’ role in orthopedic surgery.

As a quick reminder, Globus Medical acquired substantially all of the assets of StelKast, a manufacturer of knee and hip replacement implants and instruments, in 2Q19. Globus is expected to commercialize a robotic system for joint replacement in late 2020.

During our conversation, Globus Senior Vice President of Business Development Brian Kearns and Senior Vice President and CFO Keith Pfeil shared why they entered joint replacement and how they plan to compete with major joint players. They also noted a future as a complete musculoskeletal company, including a presence in sports medicine.

While prepping our 2019 revenue projections for public companies, we noted major drivers of the year. Download the spreadsheet, 2019 Revenue Projections by Company by Segment , and read the backstories.

Frank Bono credits his decades-long orthopedic career to his dog. Today, thanks to Spike, he can share what he s learned at startups and large corporations, offer advice for the next generation of new hires and voice his thoughts on extremities innovation.

Meet Your New ORTHOWORLD Bulletin!

Members: Exciting times! We’ve combined BARE BONES® and ORTHOKNOW® into one publication. This bulletin has all of the content you expect: market segment reviews, industry trend-tracking, financial recaps, strategic initiatives, product and company performance...nothing has been eliminated.

Click the bulletin cover to start reading!

Johnson & Johnson Medical Shanghai entered co-marketing, distribution and R&D agreements with TINAVI, which has the only arm-based robotic technology with multiple indications approved for use in spine and trauma in China.

Optimal, a provider of automated logistics inventory services, will support next-day distribution of WishBone s single-use, sterile packed pediatric orthopedic implants to hospitals and ASCs anywhere in the world.

Synaptive entered into a co-marketing collaboration with Stryker s Advanced Guidance Technologies for the robotically controlled Modus-V digital microscope.

The transaction is expected to close in the second half of 2020, providing Stryker with a specialized international upper extremities salesforce, access to BLUEPRINT 3D planning software and Augment injectable biologic treatment for the ankle and hindfoot.

The BioPrax device is a minimally invasive electrical stimulation tool in development to help eliminate biofilm infections on knee implants during early intervention procedures.

CoLink can be used in the calcaneus, iliac crest, proximal tibia, distal tibia and distal femur, morselizing cancellous bone to support healing in fusion and fracture stabilization.

The new clinical study illustrates the successful treatment of large and massive rotator cuff tears.

The company can now market the Arrow Prime Anatomic Shoulder in Japan to treat complex fractured shoulder reconstructions and total joint replacements resulting from wear or trauma.

The third quarter brought standout performances from some large players like Stryker, Medtronic, NuVasive and Globus Medical. Notably, the top performing players all have well-established enabling technology on the market or, in the case of NuVasive, a finely-honed procedural selling strategy.

X-BOLT Orthopaedics' technology has been shown to significantly reduce the reoperation rate. We talk
X-BOLT's surgeon founder and CEO about the company's path to commercialization.
This eNewsletter is published by ORTHOWORLD Inc. and is available to Members of ORTHOWORLD or by email subscription . Copyright © 2019. All rights reserved.

Carolyn LaWell, Chief Content Officer | carolyn@orthoworld.com
Julie A. Vetalice, Editorial Assistant | julie@orthoworld.com